COVID-19 and Global Valuation Impacts: Spotlight on Argentina & Brazil

Webcast Replay: Global valuation impacts spotlight: Argentina and Brazil.

COVID-19: An Orderly Repricing of Risk in Private Debt

The only comparable event to the spread of the virus for modern private capital markets is the Great Recession, but there are some key differences this time.

COVID-19 and Global Valuation Impacts: Spotlight on Australia, Canada, & the U.K.

Webcast Replay: Global valuation impacts spotlight: Australia, Canada, and the U.K.

COVID-19 and Portfolio Securities Valuation: Understanding the Impacts on Credit Spread

While secondary indexes are good barometers of investor sentiment and market trends, the levels reflected may not fully reflect company fundamentals and deal pricing, reflecting the new normal in a COVID-19 economic environment.

VRC’s PJ Patel to Present PLI Webinar

The unprecedented disruption businesses face from the impact of COVID-19 on their operations and finances, as well as on the overall economy, have created complex and intricate challenges in goodwill impairment testing processes.

COVID-19: Anxious Times for Financial Statement Preparers Worried About Goodwill Impairment

The impact of the proliferation of coronavirus cases on financial markets is creating challenges for companies attempting to wrap up quarterly reporting.

Bulls vs. Bears vs. COVID-19: How do Control Premiums Change?

In light of the current market downturn, can we anticipate the impact on control premiums? VRC analyzed the data.

COVID-19: Measuring Triggering Event Impacts and Subsequent Impairment Testing

Some of the most significant financial consequences of the novel coronavirus will be seen in both current and coming company disclosures.

PJ Patel to Participate in SEC Professionals Group Corona Conversations Webinar

PJ Patel will connect with SEC Professionals members and share his insights on the impact of the Coronavirus.

COVID-19: Spotlight on Goodwill Impairment Testing

Goodwill Impairment Testing: Is the novel Coronavirus a triggering event and should it be addressed for Q1 or Q2 2020?